Lv6
1660 积分 2023-06-16 加入
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR
5天前
已完结
Mutation analysis of the EGFR gene and its downstream signaling pathway in thymic carcinoma patients from a Chinese Han population
5天前
已完结
A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3
5天前
已完结
EGFR Pathway-Based Gene Signatures of Druggable Gene Mutations in Melanoma, Breast, Lung, and Thyroid Cancers
5天前
已完结
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
9天前
已完结
中国食管癌早诊早治专家共识
11天前
已完结
复发转移性宫颈癌诊疗指南（2025版）
14天前
已完结
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
23天前
已完结
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
23天前
已完结
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis
23天前
已完结
皖公网安备34019202002308
